ABG 15 (Morphine sulphate extended-release 15 mg)
Pill imprint ABG 15 has been identified as Morphine sulphate extended-release 15 mg.
Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
- ABG 15
- 15 mg
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Watson Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00591-3740||Watson Pharmaceuticals, Inc. (now Actavis, Inc)|
|66336-0172||Dispensing Solutions Inc. (repackager)|
|49999-0845||Lake Erie Medical and Surgical Supply (repackager)|
|54868-5132||Physicians Total Care Inc (repackager)|
|16590-0645||Stat RX USA LLC (repackager)|
|10544-0401||Blenheim Pharmacal Inc (repackager)|
Note: Inactive ingredients may vary.
More about morphine
- Morphine concentrate
- Morphine extended-release capsules
- Morphine immediate-release
- Morphine immediate-release tablets
- More (8) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.